Similar Papers

Paper Title
Journal
Date
Author
Dalbavancin: First I.V. antibiotic for acute bacterial skin infections
Cara Aldridge Young
Pharmacy Today | VOL. 20
Cara Aldridge YoungCara Aldridge Young
01 Jul 2014
The interplay between acute bacterial skin and skin structure infections and depression: a vicious circle of major clinical importance.
Matteo Bassetti ... Matteo Balestrieri
Current opinion in infectious diseases | VOL. 33
Matteo Bassetti, et. al.Matteo Bassetti ... Matteo Balestrieri
01 Apr 2020
99 A Single Dose of Oritavancin Compared to 7 to 10 Days of Vancomycin: Lesion Size Reduction in Phase 3 Studies of Acute Bacterial Skin and Skin Infections
C.V Pollack ... M.W Wikler
Annals of Emergency Medicine | VOL. 64
C.V Pollack, et. al.C.V Pollack ... M.W Wikler
23 Sep 2014
Dalbavancin: A New Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Portugal
Helena Sofia Antao ... Joao Paulo Guimaraes
Health Economics & Outcome Research: Open Access | VOL. 03
Helena Sofia Antao, et. al.Helena Sofia Antao ... Joao Paulo Guimaraes
01 Jan 2017
View more papers

More From: Antibiotics

Paper Title
Journal
Date
Author
Long-Acting Antibiotics: New Opportunities Beyond Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)!
Emanuele Pontali ... Francesca Mattioli
Antibiotics | VOL. -
Emanuele Pontali, et. al.Emanuele Pontali ... Francesca Mattioli
07 Feb 2025
Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review
Maria Tsouprou ... Dafni Moriki
Antibiotics | VOL. -
Maria Tsouprou, et. al.Maria Tsouprou ... Dafni Moriki
07 Feb 2025
FDA-Approved Antibacterials and Echinocandins
Othman Al Musaimi
Antibiotics | VOL. -
Othman Al MusaimiOthman Al Musaimi
07 Feb 2025
Menadione as Antibiotic Adjuvant Against P. aeruginosa: Mechanism of Action, Efficacy and Safety
Kristela Shehu ... Annette Kraegeloh
Antibiotics | VOL. -
Kristela Shehu, et. al.Kristela Shehu ... Annette Kraegeloh
07 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.